Evidence map›Paper›PMID 34626756›Full record

ReviewBrazilian journal of anesthesiology (Elsevier)

Clinical use of tranexamic acid: evidences and controversies.

Maria J Colomina, Laura Contreras, Patricia Guilabert, Maylin Koo, Esther M Ndez, Antoni Sabate

3 registry-linked trialsOpen access · diamondAbstract readReview
In one paragraph

Review in Brazilian journal of anesthesiology (Elsevier). The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 36 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 5 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06427850 nanot yet recruitingnot on this map

Effect of Topical Tranexamic Acid on Postoperative Drainage in Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI-TLIF): A Randomized Controlled Trial

TypeinterventionalSponsorThanawan LongsuwanRan2024 to 2026Enrolled28ConditionsDegenerative Spine Diseases, Surgical WoundArmsTranexamic acid, Normal saline
NCT06450392 phase4recruitingnot on this map

The Effect of Local and Systemic Tranexamic Acid on Edema and Ecchymosis in Orbital Surgery - a Prospective, Multicenter, Randomized, Double-blinded, Control Trial

TypeinterventionalSponsorMontefiore Medical CenterRan2024 to 2027Enrolled150ConditionsOrbital Edema, Orbital EcchymosisArmsTranexamic acid injection, Tranexamic Acid in NaCl,Iso-Os 1,000 Mg/100 mL (10 Mg/mL) INTRAVEN INTRAVENOUS SOLUTION, PIGGYBACK (ML), normal saline - injection, normal saline - intravenous
NCT07392034 phase2completednot on this map

Efficacy of Tranexamic Acid Reducing Blood Loss During Maxillofacial Trauma Surgery

TypeinterventionalSponsorNishtar Medical UniversityRan2025 to 2025Enrolled60ConditionsHemoglobin Level Measurement, Blood Loss During Surgery, Duration of SurgeryArmsTranexamic Acid (TXA), Normal saline
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 5 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Tranexamic acid-induced anaphylaxis: a systematic review.European journal of clinical pharmacology · 2025
    Pooled it
  5. Efficacy of tranexamic acid application in gynecology and obstetrics procedures: a umbrella review of systematic reviews of randomized trials.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2025
    Pooled it
  6. Effect of Prophylactic Intraoperative Tranexamic Acid on Postpartum Blood Loss Following Cesarean Section at a Single Center.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Influence of Antithrombotics on Severely Injured Patients Over 50 With Blunt Abdominal Trauma.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Maria J ColominaBellvitge University Hospital, Department of Anaesthesia, Critical Care & Pain, Barcelona, Spain; Barcelona University, Barcelona, Spain. Electronic address: mjcolomina@bellvitgehospital.cat.
Laura ContrerasBellvitge University Hospital, Department of Anaesthesia, Critical Care & Pain, Barcelona, Spain.
Patricia GuilabertUniversitat Aut..noma de Barcelona, Vall d.ÇÖHebron University Hospital, Department of Anaesthesia, Critical Care & Pain, Barcelona, Spain.
Maylin KooBellvitge University Hospital, Department of Anaesthesia, Critical Care & Pain, Barcelona, Spain; Barcelona University, Barcelona, Spain.
Esther M NdezBellvitge University Hospital, Department of Anaesthesia, Critical Care & Pain, Barcelona, Spain.
Antoni SabateBellvitge University Hospital, Department of Anaesthesia, Critical Care & Pain, Barcelona, Spain; Barcelona University, Barcelona, Spain.
Bellvitge University Hospital · ESUniversitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tranexamic acid (TXA) significantly reduces blood loss in a wide range of surgical procedures and improves survival rates in obstetric and trauma patients with severe bleeding. Although it mainly acts as a fibrinolysis inhibitor, it also has an anti-inflammatory effect, and may help attenuate the systemic inflammatory response syndrome found in some cardiac surgery patients. However, the administration of high doses of TXA has been associated with seizures and other adverse effects that increase the cost of care, and the administration of TXA to reduce perioperative bleeding needs to be standardized. Tranexamic acid is generally well tolerated, and most adverse reactions are considered mild or moderate. Severe events are rare in clinical trials, and literature reviews have shown tranexamic acid to be safe in several different surgical procedures. However, after many years of experience with TXA in various fields, such as orthopedic surgery, clinicians are now querying whether the dosage, route and interval of administration currently used and the methods used to control and analyze the antifibrinolytic mechanism of TXA are really optimal. These issues need to be evaluated and reviewed using the latest evidence to improve the safety and effectiveness of TXA in treating intracranial hemorrhage and bleeding in procedures such as liver transplantation, and cardiac, trauma and obstetric surgery.

Indexed as

Antifibrinolytic AgentsOrthopedic ProceduresTranexamic AcidBlood Loss, SurgicalFemaleHemorrhageHumansPregnancyAntifibrinolytic AgentsTranexamic AcidAntifibrinolyticsCardiac surgeryLiver surgeryObstetric hemorrhageOrthopedic surgerySubarachnoid hemorrhageTranexamic acidTrauma

Identifiers

PMID34626756
PMCPMC9660007
OpenAlexW3204607528

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.